These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 28156061

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX, Qi Y, Zhang J, Liu Y, Xu WH, Xu J, Hu HG, Wu QY, Wang Y, Zhang JP.
    Oncotarget; 2016 Nov 29; 7(48):79544-79556. PubMed ID: 27783993
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma.
    Lai KP, Chen J, He M, Ching AK, Lau C, Lai PB, To KF, Wong N.
    Int J Cancer; 2014 Oct 15; 135(8):1790-9. PubMed ID: 24585547
    [Abstract] [Full Text] [Related]

  • 4. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM-/CD133- nonStem Cells into EpCAM+/CD133+ Liver Cancer Stem Cells in HCC Cell Line HuH7.
    Karagonlar ZF, Akbari S, Karabicici M, Sahin E, Avci ST, Ersoy N, Ates KE, Balli T, Karacicek B, Kaplan KN, Celiker C, Atabey N, Erdal E.
    Cells; 2020 May 12; 9(5):. PubMed ID: 32408542
    [Abstract] [Full Text] [Related]

  • 5. Effect of Over-Expression of Zinc-Finger Protein (ZFX) on Self-Renewal and Drug-Resistance of Hepatocellular Carcinoma.
    Zhang S, Shu R, Yue M, Zhang S.
    Med Sci Monit; 2016 Aug 27; 22():3025-34. PubMed ID: 27566731
    [Abstract] [Full Text] [Related]

  • 6. Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway.
    Cheng Z, Lei Z, Yang P, Si A, Xiang D, Zhou J, Hüser N.
    Gene; 2019 Feb 05; 684():95-103. PubMed ID: 30359743
    [Abstract] [Full Text] [Related]

  • 7. PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma.
    Li M, Mu XD, Song JR, Zhai PT, Cheng Y, Le Y, Li ZB.
    Cell Cycle; 2021 May 05; 20(10):1010-1020. PubMed ID: 33970778
    [Abstract] [Full Text] [Related]

  • 8. Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients.
    Xiang D, Cheng Z, Liu H, Wang X, Han T, Sun W, Li X, Yang W, Chen C, Xia M, Liu N, Yin S, Jin G, Lee T, Dong L, Hu H, Wang H, Ding J.
    Hepatology; 2017 May 05; 65(5):1566-1580. PubMed ID: 28059452
    [Abstract] [Full Text] [Related]

  • 9. EpCAM+ Liver Cancer Stem-Like Cells Exhibiting Autocrine Wnt Signaling Potentially Originate in Cirrhotic Patients.
    Khosla R, Rastogi A, Ramakrishna G, Pamecha V, Mukhopadhyay A, Vasudevan M, Sarin SK, Trehanpati N.
    Stem Cells Transl Med; 2017 Mar 05; 6(3):807-818. PubMed ID: 28176469
    [Abstract] [Full Text] [Related]

  • 10. Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression.
    Deng Y, Li M, Zhuo M, Guo P, Chen Q, Mo P, Li W, Yu C.
    J Biol Chem; 2021 Mar 05; 296():100121. PubMed ID: 33434575
    [Abstract] [Full Text] [Related]

  • 11. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.
    Park DJ, Sung PS, Kim JH, Lee GW, Jang JW, Jung ES, Bae SH, Choi JY, Yoon SK.
    J Immunother Cancer; 2020 Mar 05; 8(1):. PubMed ID: 32221015
    [Abstract] [Full Text] [Related]

  • 12. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y, Wang Y, Gong J, Rao L, Wu Z, Nie T, Shi D, Zhang L.
    Int J Oncol; 2018 Jan 05; 52(1):219-230. PubMed ID: 29138811
    [Abstract] [Full Text] [Related]

  • 13. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.
    Yang C, Cai WC, Dong ZT, Guo JW, Zhao YJ, Sui CJ, Yang JM.
    Gene; 2019 Mar 01; 687():73-81. PubMed ID: 30391438
    [Abstract] [Full Text] [Related]

  • 14. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
    Feng H, Zhu M, Zhang R, Wang Q, Li W, Dong X, Chen Y, Lu Y, Liu K, Lin B, Guo J, Li M.
    J Cell Mol Med; 2019 Apr 01; 23(4):2536-2548. PubMed ID: 30672133
    [Abstract] [Full Text] [Related]

  • 15. Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90.
    Yoshida M, Yamashita T, Okada H, Oishi N, Nio K, Hayashi T, Nomura Y, Hayashi T, Asahina Y, Ohwada M, Sunagozaka H, Takatori H, Colombo F, Porretti L, Honda M, Kaneko S.
    Sci Rep; 2017 Sep 12; 7(1):11292. PubMed ID: 28900199
    [Abstract] [Full Text] [Related]

  • 16. Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM+ Hepatocellular Carcinoma.
    Takai A, Dang H, Oishi N, Khatib S, Martin SP, Dominguez DA, Luo J, Bagni R, Wu X, Powell K, Ye QH, Jia HL, Qin LX, Chen J, Mitchell GA, Luo X, Thorgeirsson SS, Wang XW.
    Cancer Res; 2019 May 01; 79(9):2379-2391. PubMed ID: 30862714
    [Abstract] [Full Text] [Related]

  • 17. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.
    Yamashita T, Honda M, Nakamoto Y, Baba M, Nio K, Hara Y, Zeng SS, Hayashi T, Kondo M, Takatori H, Yamashita T, Mizukoshi E, Ikeda H, Zen Y, Takamura H, Wang XW, Kaneko S.
    Hepatology; 2013 Apr 01; 57(4):1484-97. PubMed ID: 23174907
    [Abstract] [Full Text] [Related]

  • 18. EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
    Leung HW, Leung CON, Lau EY, Chung KPS, Mok EH, Lei MML, Leung RWH, Tong M, Keng VW, Ma C, Zhao Q, Ng IOL, Ma S, Lee TK.
    Cancer Res; 2021 Jun 15; 81(12):3229-3240. PubMed ID: 33903122
    [Abstract] [Full Text] [Related]

  • 19. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC.
    Khosla R, Hemati H, Rastogi A, Ramakrishna G, Sarin SK, Trehanpati N.
    Liver Int; 2019 Sep 15; 39(9):1692-1703. PubMed ID: 31276277
    [Abstract] [Full Text] [Related]

  • 20. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
    Nio K, Yamashita T, Okada H, Kondo M, Hayashi T, Hara Y, Nomura Y, Zeng SS, Yoshida M, Hayashi T, Sunagozaka H, Oishi N, Honda M, Kaneko S.
    J Hepatol; 2015 Nov 15; 63(5):1164-72. PubMed ID: 26095183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.